Harris Rotman's most recent trade in Centessa Pharmaceuticals plc - ADR was a trade of 75,000 Share Option (right to buy) done . Disclosure was reported to the exchange on Feb. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals p... | Harris Rotman | SVP Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 75,000 | 75,000 | - | - | Share Option (right to buy) | |
| Centessa Pharmaceuticals p... | Harris Rotman | SVP Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 37,500 | 71,000 | - | 0 | Ordinary Shares | |
| Centessa Pharmaceuticals p... | Harris Rotman | SVP Regulatory Affairs | Sale of securities on an exchange or to another person at price $ 8.10 per share. | 01 Feb 2024 | 4,267 | 62,625 | - | 8.1 | 34,574 | Ordinary Shares |
| Centessa Pharmaceuticals p... | Harris Rotman | SVP Regulatory Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 01 Feb 2024 | 4,108 | 66,892 | - | 8.2 | 33,645 | Ordinary Shares |